Kimberly-Clark Corporation, a core S&P 500 component, today announced that it has completed its acquisition of Kenvue. The combination creates the preeminent global consumer health and wellness leader, uniting leading portfolios, including 10 billion-dollar brands, to deliver extraordinary care for billions of people across every stage of life.
“Today marks a defining moment in Kimberly-Clark’s 154-year history as we welcome Kenvue and hit the ground running as one company,” said Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark. “I am deeply grateful to our Kimberly-Clark and Kenvue teams around the world for enabling this next step. We share a rich heritage: pioneering entire categories and forming deep, lifelong bonds with consumers around the world as we help generations of people take care of themselves and their loved ones, every day. Now, at a moment when the need for better care is undeniable and growing, we have an urgent opportunity to be there for more people, in more places and across evolving unmet needs. With Kenvue, Kimberly-Clark is equipped to combine deep consumer insight, groundbreaking science and innovation, brand-building expertise and strong commercial execution to lead the future of consumer health.”
Hsu continued, “Our focus now is to move with speed and purpose to unlock the full potential of this combination. I am confident that our shared commitment to care and strong execution will enable us to deliver generational value for consumers, customers and shareholders.”
Extraordinary Starts Today
- Uniting leading, trusted and iconic brands to create the preeminent global consumer health and wellness leader. The company’s combined portfolio of leading personal care and consumer health brands includes 10 billion-dollar brands: Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson’s Baby, Kotex and Scott.
- Leading attractive categories at the intersection of fast-moving consumer goods and healthcare. Healthcare has become more personal, proactive, and essential as consumers are underserved by traditional healthcare systems, leaving them to assemble their own solutions. The company leads in many of the industry’s largest, most attractive categories, including baby care, women’s health and active aging. As global spending on health and wellness reaches more than $500 billion annually, Kimberly-Clark is well positioned to capture growing demand for science-backed, high-quality and high-performance solutions across everyday needs.
- Elevating the standard of care through three strategic pillars: Better Care, More Hands and Smarter Health. The company’s combined brands will serve consumers more comprehensively throughout their health and care journeys, raising the bar on everyday care. Kimberly-Clark will extend its reach to more people in more places, across evolving needs.
- Deploying Kimberly-Clark’s proven growth engine with best-in-class execution and management. Kimberly-Clark’s Powering Care growth engine will enhance the performance and potential of Kenvue’s portfolio by accelerating innovation, deepening brand love and improving commercial execution. Kimberly-Clark has appointed a purpose-built leadership team with the right experience, capabilities and technical expertise to drive a focus on winning in the company’s local markets.
- Delivering a differentiated financial framework supported by substantial synergies. Kimberly-Clark reaffirms anticipated run-rate synergies of approximately $2.1 billion, consisting of approximately $1.9 billion in cost synergies, captured in the first three years following close, and approximately $500 million in incremental profit from revenue synergies, partially offset by reinvestment of approximately $300 million, captured within four years post-close. The company has substantially built its pipeline of cost and revenue initiatives as part of a robust integration plan.
Segments and Leadership for Best-in-Class Execution
As previously announced, Kimberly-Clark will operate with four business segments:
- North America, a business generating approximately $18.0 billion1 in sales annually;
- Asia Pacific Focus Markets, which will include Greater China, Australia / New Zealand, South Korea, and Indonesia, generating approximately $4.3 billion1 in annual sales;
- Europe, Middle East, and Africa (EMEA), with approximately $5.0 billion1 in annual sales; and
- Enterprise Markets, which will include Latin America (including Brazil), India, Southeast Asia markets, and Japan, generating approximately $4.3 billion1 in annual sales.
Board and Governance
As previously announced, three members of the Kenvue Board of Directors have joined the Kimberly-Clark Board of Directors, which now comprises 13 directors:
- Mike Hsu, Chairman and CEO
- Sherilyn S. McCoy, Lead Independent Director
- Richard E. Allison, Jr.
- Sylvia M. Burwell
- John W. Culver
- Deeptha Khanna
- S. Todd Maclin
- Deirdre A. Mahlan
- Larry Merlo
- Kirk Perry
- Joseph Romanelli
- Dunia A. Shive
- Mark T. Smucker
In connection with the close of the transaction, Mae C. Jemison, Christa S. Quarles and Jaime A. Ramirez have stepped down from the Kimberly-Clark Board effective immediately.
Transaction Details
With the completion of the transaction, Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each Kenvue share held. Shares of Kenvue’s common stock, which traded on the New York Stock Exchange under the symbol “KVUE,” ceased trading as of the market opening on November 2, 2026.
Photo/Kimberly-Clark
RELATED NEWS
